[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The 800-lb Chinese Gorilla]( [Find Out Where This Copper Hotspot Is and How You Can Benefit]( --------------------------------------------------------------- January 13, 2023 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [The Humble Mineral at the Heart of the EV Revolution (Not Lithium)]( may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite - more than lithium, copper or aluminum! [Get the Full Story On This New American Graphite Opportunity]( --------------------------------------------------------------- [EyePoint Pharmaceuticals, EYPT]( Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [EyePoint Pharmaceuticals (EYPT)](in the Healthcare sector with a Buy rating and a price target of $25.00 (3 days ago). - Recent Price: $$5.48 - Average Analyst Price Target: $32.80 (498.54%) - Market Cap: $$168.71M [TipRanks.com]( also reports that [EyePoint Pharmaceuticals](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $32.80 . The target pricing ranges from a high forecast of $52.00 down to a low forecast of $21.00. [EyePoint Pharmaceuticals (EYPT)](’s last closing price was $$5.48 which would put the average price target at $$32.80. Here are 3rd party ratings for [EYPT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 24% (59 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Dividend Expert Reveals His Biggest Income Secrets... Free of Charge]( Marc Lichtenfeld –Author of the best-selling book Get Rich With Dividends – is giving away his Ultimate Dividend Package… [Free of charge!]( [Click Here to Get His #1 Dividend Stock… The Safest 9% Dividend in the World… Top Three “Extreme Dividend” Stocks, And Much, Much More]( --------------------------------------------------------------- [Hall of Fame Resort & Entertainment, HOFV]( Recent Analyst Action: Michael Diana, analyst at Maxim Group, reiterates coverage on [Hall of Fame Resort & Entertainment (HOFV)](in the Services sector with a Buy rating and a price target of $3.00 (1 month ago). - Recent Price: $$15.74 - Average Analyst Price Target: $3.00 (-80.94%) - Market Cap: $$84.64M [TipRanks.com]( also reports that [Hall of Fame Resort & Entertainment](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.00 . The target pricing ranges from a high forecast of $3.00 down to a low forecast of $3.00. [Hall of Fame Resort & Entertainment (HOFV)](’s last closing price was $$15.74 which would put the average price target at $$3.00. Here are 3rd party ratings for [HOFV](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Fulcrum Therapeutics, FULC]( Recent Analyst Action: Edward Tenthoff, analyst at Piper Sandler, reiterates coverage on [Fulcrum Therapeutics (FULC)](in the Healthcare sector with a Buy rating and a price target of $18.00 (1 week ago). - Recent Price: $$14.53 - Average Analyst Price Target: $22.71 (56.30%) - Market Cap: $$727.16M [TipRanks.com]( also reports that [Fulcrum Therapeutics](currently has 8 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $22.71 . The target pricing ranges from a high forecast of $35.00 down to a low forecast of $11.00. [Fulcrum Therapeutics (FULC)](’s last closing price was $$14.53 which would put the average price target at $$22.71. Here are 3rd party ratings for [FULC](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 24% (59 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [IGM Biosciences, IGMS]( Recent Analyst Action: Roger Song, analyst at Jefferies, reiterates coverage on [IGM Biosciences (IGMS)](in the Healthcare sector with a Buy rating and a price target of $55.00 (3 days ago). - Recent Price: $$24.66 - Average Analyst Price Target: $39.80 (61.39%) - Market Cap: $$1.05B [TipRanks.com]( also reports that [IGM Biosciences](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $39.80 . The target pricing ranges from a high forecast of $55.00 down to a low forecast of $22.00. [IGM Biosciences (IGMS)](’s last closing price was $$24.66 which would put the average price target at $$39.80. Here are 3rd party ratings for [IGMS](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 24% (59 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Voyager Therapeutics, VYGR]( Recent Analyst Action: Jack Allen, analyst at Robert W. Baird, reiterates coverage on [Voyager Therapeutics (VYGR)](in the Healthcare sector with a Buy rating and a price target of $12.00 (4 days ago). - Recent Price: $$10.25 - Average Analyst Price Target: $12.00 (17.07%) - Market Cap: $$358.66M [TipRanks.com]( also reports that [Voyager Therapeutics](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.00 . The target pricing ranges from a high forecast of $12.00 down to a low forecast of $12.00. [Voyager Therapeutics (VYGR)](’s last closing price was $$10.25 which would put the average price target at $$12.00. Here are 3rd party ratings for [VYGR](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Top 24% (59 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Why is Russia reopening dormant copper mines?]( deepest Siberia, Russian oligarchs are pouring $15 billion into two long-dormant copper mines with close access to the lucrative China market. Copper is essential to the West's plans to transition to green energy and Russia has the third-largest reserves in the world. Is Putin making a move to corner the copper market? New sources of copper – outside Russia – are desperately needed for the West to win its war for energy independence. [Here's where to look]( --------------------------------------------------------------- [American Superconductor, AMSC]( Recent Analyst Action: Eirik Haavaldsen, analyst at Pareto, reiterates coverage on [American Superconductor (AMSC)](in the Industrial Goods sector with a Hold rating and a price target of $6.80 (1 month ago). - Recent Price: $$4.965 - Average Analyst Price Target: $9.40 (89.33%) - Market Cap: $$138.30M [TipRanks.com]( also reports that [American Superconductor](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $9.40 . The target pricing ranges from a high forecast of $12.00 down to a low forecast of $6.80. [American Superconductor (AMSC)](’s last closing price was $$4.965 which would put the average price target at $$9.40. Here are 3rd party ratings for [AMSC](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 36% (89 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Cellectis SA, CLLS]( Recent Analyst Action: Yigal Nochomovitz, analyst at Citigroup, reiterates coverage on [Cellectis SA (CLLS)](in the Healthcare sector with a Buy rating and a price target of $24.00 (4 weeks ago). - Recent Price: $$3.86 - Average Analyst Price Target: $14.75 (282.12%) - Market Cap: $$169.72M [TipRanks.com]( also reports that [Cellectis SA](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $14.75 . The target pricing ranges from a high forecast of $24.00 down to a low forecast of $10.00. [Cellectis SA (CLLS)](’s last closing price was $$3.86 which would put the average price target at $$14.75. Here are 3rd party ratings for [CLLS](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 24% (59 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["We need batteries. Literally everywhere."]( much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense." [Read about this company's once-in-a-lifetime graphite opportunity -- before Wall Street]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software